Literature DB >> 16091786

Expression of proteinase-activated receptor 2 on human primary gastrointestinal myofibroblasts and stimulation of prostaglandin synthesis.

Michelle L Seymour1, David G Binion, Steven J Compton, Morley D Hollenberg, Wallace K MacNaughton.   

Abstract

It is known that subepithelial myofibroblast-derived prostaglandin (PG)E2 can regulate intestinal epithelial cell functions, and that proteinase-activated receptor-2 (PAR2) is abundantly expressed in the gastrointestinal tract. Since PAR2 activation has previously been associated with stimulation of PGE2 synthesis, we hypothesized that PAR2 expressed on primary human gastrointestinal myofibroblasts regulates PGE2 synthesis via cyclooxygenase (COX)-1 and (or) COX-2, and associated PGE synthases. Primary human myofibroblasts were isolated from the resection tissue of the esophagus, small intestine, and colon. Expression of functional PAR2 was determined by RT-PCR and by calcium mobilization in Fura-2/AM-loaded cells. Trypsin and the selective PAR2-activating peptide (PAR2-AP) SLIGRL-NH2 stimulated PGE2 synthesis in a concentration-dependent manner, as measured by enzyme immunoassay. Selective COX inhibition showed PAR2-induced PGE2 synthesis to be COX-1 dependent in esophageal myofibroblasts and both COX-1 and COX-2 dependent in colonic cells, consistent with the distribution of COX-1 and COX-2 expression. Although both cytosolic and microsomal PGE synthases were expressed in cells from all tissues, microsomal PGE synthases were expressed at highest levels in the colonic myofibroblasts. Activation of PAR2 on gastrointestinal myofibroblasts stimulates PGE2 synthesis via different pathways in the colon than in the esophagus and small intestine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091786     DOI: 10.1139/y05-046

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

Review 1.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

Review 2.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

3.  Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis.

Authors:  Eric Hyun; Patricia Andrade-Gordon; Martin Steinhoff; Paul L Beck; Nathalie Vergnolle
Journal:  Inflamm Res       Date:  2010-03-26       Impact factor: 4.575

4.  Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.

Authors:  Dániel Szűcs; Nóra Judit Béres; Réka Rokonay; Kriszta Boros; Katalin Borka; Zoltán Kiss; András Arató; Attila J Szabó; Ádám Vannay; Erna Sziksz; Csaba Bereczki; Gábor Veres
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

5.  Effect of Protease-Activated Receptor-2-Activating Peptide on Guinea Pig Airway Resistance and Isolated Tracheal Strips.

Authors:  Magda M Hagras; Fatemah O Kamel
Journal:  J Microsc Ultrastruct       Date:  2019-09-24

6.  Activity of protease-activated receptors in primary cultured human myenteric neurons.

Authors:  Eva M Kugler; Gemma Mazzuoli; Ihsan E Demir; Güralp O Ceyhan; Florian Zeller; Michael Schemann
Journal:  Front Neurosci       Date:  2012-09-12       Impact factor: 4.677

7.  Role of IL-24 in the mucosal remodeling of children with coeliac disease.

Authors:  Réka Rokonay; Apor Veres-Székely; Beáta Szebeni; Domonkos Pap; Rita Lippai; Nóra J Béres; Gábor Veres; Attila J Szabó; Ádám Vannay
Journal:  J Transl Med       Date:  2020-01-23       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.